SCHEMBL13488291

SCHEMBL13488291

Cc1ccc2c(-c3ccc(-c4ccccc4)cc3)c3ccccc3c(-c3ccc4c(c3)N(C)c3ccccc3C=C4)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
KDM4E B2RXH2 3/20 0.38
HTT P42858 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 2/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 2/20 0.38
RECQL P46063 2/20 0.38
BLM P54132 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NSD2 O96028 1/20 0.38
RAD52 P43351 1/20 0.38
MMP14 P50281 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ACHE P22303 2/20 0.35
PTGS2 P35354 2/20 0.33
MAPK8 P45983 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13488288 0.99 MEN1 (0.39) MEN1KMT2AKDM4EHTTNPC1
SCHEMBL13488284 0.88 AKT1 (0.39) MEN1KMT2AKDM4EHTTNPC1
SCHEMBL13488319 0.87 PTGS2 (0.37) MEN1KMT2AKDM4EHTTLMNA
SCHEMBL13488313 0.86 PTGS2 (0.38) MEN1KMT2AKDM4EHTTLMNA
SCHEMBL13488292 0.85 MEN1 (0.35) MEN1KMT2AKDM4EHTTNPC1
SCHEMBL13488294 0.85 POLB (0.35) MEN1KMT2AKDM4EHTTNPC1
SCHEMBL13487493 0.82 KDM4E (0.33) MEN1KMT2AKDM4EHTTNPC1
SCHEMBL13488290 0.82 KDM4E (0.35) MEN1KMT2AKDM4EHTTNPC1
SCHEMBL13487880 0.82 KDM4E (0.35) MEN1KMT2AKDM4EHTTNPC1
SCHEMBL13488330 0.81 MAOA (0.46) MEN1KMT2ANPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
EP-2108689-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 MEN1 3017/4885KMT2A 3530/4885KDM4E 3671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.